Clinical trial
The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's…
NCT00165815 · Eisai Limited, Industry · Completed
Key facts
| NCT number | NCT00165815 |
|---|---|
| Title | The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia |
| Lead sponsor | Eisai Limited, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dementia With Parkinson's Disease |
| Intervention type | Drug |
| Interventions | ARICEPT |
| Start date | Aug 1, 2002 |
| Completion | Jul 1, 2005 |
| First posted | Sep 14, 2005 |
| Last update posted | May 10, 2013 |
| Countries | Germany, Ireland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: